Anika Therapeutics Inc (NASDAQ:ANIK) – Analysts at First Analysis decreased their Q2 2016 earnings estimates for shares of Anika Therapeutics in a research note issued on Friday, according to Zacks Investment Research. First Analysis analyst now forecasts that the firm will post earnings of $0.38 per share for the quarter, down from their previous forecast […]
